M&A · Healthcare · Buyer's industry: Pharmaceutical Preparations
Heat Biologics, Inc. to acquire Elusys Therapeutics
Announced Dec 21, 2021 · Closed Apr 20, 2022 · Private target
Deal value—
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationNot disclosed
Transaction
- Acquirer
- Heat Biologics, Inc. (HTBX)
- Target
- Elusys Therapeutics
- Buyer type
- Strategic
- Offer price per share
- —
- Enterprise value
- —
- Status
- Closed Apr 20, 2022
Deal protections
Not disclosed for private-company acquisitions.
Advisors
- To the acquirer
- Not disclosed
- To the target
- RBC Capital Markets
Classification
- Sector
- Healthcare
- Buyer's industry
- Pharmaceutical Preparations